Prevention of nitroimidazole resistance in Campylobacter pylori by coadministration of colloidal bismuth subcitrate: clinical and in vitro studies.
about
Review article: bismuth-based therapy for Helicobacter pylori eradication in childrenHelicobacter pylori: Emergence of a SuperbugClinical relevance of resistant strains of Helicobacter pylori: a review of current dataTreatment of Helicobacter pylori infection: current status and future concepts.Helicobacter pylori porCDAB and oorDABC genes encode distinct pyruvate:flavodoxin and 2-oxoglutarate:acceptor oxidoreductases which mediate electron transport to NADPStandardization of disk diffusion test and its clinical significance for susceptibility testing of metronidazole against Helicobacter pylori.Review article: nitroimidazole resistance in Helicobacter pylori.Topographic association between active gastritis and Campylobacter pylori colonisation.Exposure to metronidazole in vivo readily induces resistance in Helicobacter pylori and reduces the efficacy of eradication therapy in miceAntimicrobial susceptibility testing of Helicobacter pylori in a large multicenter trial: the MACH 2 studyClarithromycin for Helicobacter pylori infection.Prevalence of Helicobacter pylori infection and its effect on symptoms and non-steroidal anti-inflammatory drug induced gastrointestinal damage in patients with rheumatoid arthritis.Helicobacter pylori: bridging the credibility gapIndications for treatment of Helicobacter pylori infection: a systematic overview.Growth inhibition of metronidazole-susceptible and metronidazole-resistant strains of Gardnerella vaginalis by Lactobacilli in vitro.Eradication of Helicobacter mustelae from the ferret stomach: an animal model of Helicobacter (Campylobacter) pylori chemotherapyIn vitro selection of resistant Helicobacter pylori.Eradication of Helicobacter pylori: therapies and clinical implications.Fourteen- vs seven-day bismuth-based quadruple therapy for second-line Helicobacter pylori eradicationRole of metronidazole resistance in therapy of Helicobacter pylori infections.Antimicrobial susceptibility of Canadian isolates of Helicobacter pylori in Northeastern Ontario.Bacterial challenges and evolving antibacterial drug strategy.Quadruple therapy with moxifloxacin and bismuth for first-line treatment of Helicobacter pylori.The impact of bismuth addition to sequential treatment on Helicobacter pylori eradication: A pilot study.Effect of transport medium and transportation time on culture of Helicobacter pylori from gastric biopsy specimensEvaluation of the E test for quantitative antimicrobial susceptibility testing of Helicobacter pylori.Helicobacter pylori therapy: effect on peptic ulcer disease.Mechanisms of action of systemic antibiotics used in periodontal treatment and mechanisms of bacterial resistance to these drugs.Efficacy of 1st-line bismuth-containing quadruple therapies with levofloxacin or clarithromycin for the eradication of Helicobacter pylori infection: A 1-week, open-label, randomized trial.Nitazoxanide, a potential drug for eradication of Helicobacter pylori with no cross-resistance to metronidazole.Explanations for high rates of eradication with triple therapy using metronidazole in patients harboring metronidazole-resistant Helicobacter pylori strainsAppearance of a metronidazole-resistant Helicobacter pylori strain in an infected-ICR-mouse model and difference in eradication of metronidazole-resistant and -sensitive strainsMetabolic activities of metronidazole-sensitive and -resistant strains of Helicobacter pylori: repression of pyruvate oxidoreductase and expression of isocitrate lyase activity correlate with resistance.Bactericidal activity of antimicrobial agents against slowly growing Helicobacter pylori.Ten-Day Quadruple Therapy Comprising Proton Pump Inhibitor, Bismuth, Tetracycline, and Levofloxacin is More Effective than Standard Levofloxacin Triple Therapy in the Second-Line Treatment of Helicobacter pylori Infection: A Randomized Controlled TrRibotyping patterns and emergence of metronidazole resistance in paired clinical samples of Helicobacter pylori.In vitro studies on stability and development of metronidazole resistance in Helicobacter pylori.Rescue Therapy for Helicobacter pylori Eradication: A Randomized Non-Inferiority Trial of Amoxicillin or Tetracycline in Bismuth Quadruple Therapy.Duodenal ulcer treatment: progress from pH to HP.The action of bismuth against Helicobacter pylori mimics but is not caused by intracellular iron deprivation
P2860
Q26998597-D06B0146-A7CB-4D01-A671-E9ECFFE619F2Q27001579-B609A638-0E64-4B2F-AB36-8C49106005EDQ32003780-7B9DE03E-9134-474E-9477-C827D2484AD1Q33594850-905067AB-B175-4B4E-9BD3-4AB9F599FB0CQ33725283-F97B9694-F28F-4CCC-9B05-5F2E894AF7F3Q33761162-7E091F6D-6307-40A2-8C70-0C337D76DDB8Q33815739-8073BA69-9B93-4498-85E3-848CDC7C3363Q33840322-203D2360-BAB9-45E5-8C94-F3C415B8176BQ33976598-071A8B79-10D6-4A80-B4D0-FCE57234BFFBQ33978090-E851DB3D-DEB7-4490-8FB4-78CCF712C8F7Q34182199-1B904418-3071-4FB2-9CD3-E7CF99C227C7Q34377747-104EB9C3-51CD-416F-A30A-527BEAE54826Q34392788-B9280C7E-4D6C-450B-805D-6B45786A7646Q34707933-3F826738-EBBE-4BB4-A0F1-3AA041479592Q35189425-915F6824-991D-49CD-A397-14C1ADA451B5Q35262924-05394E2A-C28B-4E65-95AF-20EA4B0C0D63Q35271542-C096C446-3895-498C-A1D7-1E8361CBC6B7Q35531059-26E5402E-FB67-4885-8922-9970B9C11562Q35843088-AD0649C5-EFB5-4E8C-B1AB-6066F0DADBB8Q35843554-9AD8E1AF-B3F3-4060-A59D-4F960BD711D7Q35867229-B1CFA6D6-4A95-42A5-BE06-83C66F85A394Q35990358-B60953AB-958C-477B-B467-008D75EC1FF5Q36215547-235627F8-B44E-4FAA-BE52-960FAFF0D9B3Q36402306-8E8E3E52-6BB7-407B-AF42-68B2FD40A6DCQ37235417-616C2049-A67C-48E6-A71D-D7723FDAFE33Q37242990-939C9E76-578F-4A38-8BB3-63493A6754D7Q37362515-3FE78216-A694-4070-9FA3-AD2A7DC9FE29Q37437540-E53F35CB-5E3E-4AF3-B9B5-967A30FEC127Q37656247-558063E4-0EB4-4183-992A-463E189B809BQ39559363-28D737BA-8556-4263-A355-C3CA16FF690EQ39779000-6B11DA6C-F034-4445-A340-3FFFD43D1411Q39785375-D025B318-DC5D-413D-B217-4DBFE408052EQ39842339-AB0F782C-27DE-411B-ABDF-1ACF6E13CDF3Q39871004-DA947E6D-8A3B-4E89-88FB-09F4C96ABB7BQ40129982-FBE90310-F8B3-4C79-8515-B0B4A32D480DQ40198012-A75DC3D5-6712-4459-B84E-3FDBDD20D1FEQ40285071-43CB44F1-E7C1-4312-BC35-7E164DBD9380Q40526981-FC5554F2-00C4-463A-B77D-D5D20C18D37AQ40695201-251A77E9-38D7-4968-A769-DE57CBB90A2CQ40882735-6ED7DA29-58DB-46A0-A882-1BA763FB731C
P2860
Prevention of nitroimidazole resistance in Campylobacter pylori by coadministration of colloidal bismuth subcitrate: clinical and in vitro studies.
description
1988 nî lūn-bûn
@nan
1988 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
name
Prevention of nitroimidazole r ...... clinical and in vitro studies.
@ast
Prevention of nitroimidazole r ...... clinical and in vitro studies.
@en
type
label
Prevention of nitroimidazole r ...... clinical and in vitro studies.
@ast
Prevention of nitroimidazole r ...... clinical and in vitro studies.
@en
prefLabel
Prevention of nitroimidazole r ...... clinical and in vitro studies.
@ast
Prevention of nitroimidazole r ...... clinical and in vitro studies.
@en
P2093
P2860
P356
P1476
Prevention of nitroimidazole r ...... clinical and in vitro studies.
@en
P2093
Blackbourn S
Blincow ED
Goodwin CS
Phillips M
P2860
P304
P356
10.1136/JCP.41.2.207
P407
P577
1988-02-01T00:00:00Z